Fluid-induced coagulopathy: does the type of fluid make a difference?

Area of Science:

• Critical care medicine
• Pharmacology
• Hematology

Background:

• Crystalloid and colloid solutions, including hydroxyethyl starch (HES) preparations, are widely used for fluid resuscitation in critically ill patients.
• The safety profile of HES, particularly concerning its impact on blood coagulation, requires further elucidation.
• Understanding potential differences between various HES formulations, such as low-molecular and low-substituted HES, is crucial for clinical application.

Discussion:

• The precise mechanisms by which HES affects hemostasis are not fully understood.
• Existing research presents incomplete data on the coagulopathic effects of different HES products.
• Clinical use of HES is limited by the unresolved safety concerns regarding its procoagulant or anticoagulant effects.

Key Insights:

• Hydroxyethyl starch (HES) administration can potentially impair blood coagulation.
• Variability in HES molecular weight and substitution degree may influence its hemostatic effects.
• Further investigation is needed to differentiate the safety and efficacy of distinct HES preparations.

Outlook:

• Clarifying the safety of HES in critically ill patients will optimize fluid resuscitation strategies.
• Research differentiating HES types could lead to safer and more targeted clinical recommendations.
• Enhanced understanding of HES-hemostasis interactions may reduce adverse events and improve patient outcomes.